Bgc Group Inc
6 nominees · 3 ballot items.
The proxy solicits votes on three proposals: (1) election of six directors, (2) ratification of Ernst & Young LLP as the independent registered public accounting firm for 2025, and (3) approval of an advisory vote on executive compensation.
Follow how the vote landed and what changed on Bgc Group Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORTo elect six directors to hold office until the next annual meeting and until their successors are duly elected and qualified.
- 2
Ratification of Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm
ManagementBoard: FORTo ratify Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.
- 3
Approval of an Advisory Vote on Executive Compensation
ManagementBoard: FORAn advisory, non-binding vote to approve the compensation of the Named Executive Officers as disclosed in this Proxy Statement.
Nominees on the ballot6
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 8.0% | 38,450,122 | $376M |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.1% | 24,544,191 | $240M |
| 3 | Rubric Capital Management LP | 4.9% | 23,300,000 | $228M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 3.4% | 16,315,660 | $160M |
| 5 | STATE STREET CORP | 3.0% | 14,481,960 | $142M |
| 6 | BlackRock, Inc. | 2.3% | 11,057,107 | $108M |
| 7 | FMR LLC | 1.8% | 8,538,452 | $84M |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 7,701,359 | $75M |
| 9 | DIMENSIONAL FUND ADVISORS LP | 1.6% | 7,448,223 | $73M |
| 10 | Boston Partners | 1.5% | 7,193,725 | $70M |
Other Financial Services sector meetings6
Upcoming shareholder meetings at Bgc Group Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Bgc Group Inc 2025 annual meeting?
- Bgc Group Inc (BGC) holds its 2025 annual shareholder meeting on Wednesday, November 12, 2025.
- What is the record date for the Bgc Group Inc 2025 meeting?
- The record date for the Bgc Group Inc 2025 meeting is Monday, September 15, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Bgc Group Inc's 2025 meeting?
- The board is presenting 6 director nominees at the Bgc Group Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Bgc Group Inc 2025 meeting?
- Shareholders will vote on 3 proposals at the Bgc Group Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.